Medical Implant Market Surges Toward $147.46 Billion by 2027

PORTLAND, OR, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- The global medical implant market is witnessing significant growth, poised to expand from $85.38 billion in 2019 to $147.46 billion by 2027, at a CAGR of 7.2% during the forecast period of 2020 to 2027. This robust expansion is attributed to an aging population, rising prevalence of chronic illnesses, increasing insurance coverage, and rapid technological innovation in implantable devices.

Market Drivers
Several factors are fueling the demand for medical implants across the globe:

Rising incidence of chronic diseases, including cardiovascular disorders, osteoporosis, and dental issues, requiring long-term medical intervention.

Favorable insurance policies that support critical procedures involving implants, reducing financial barriers for patients.

Growing awareness and acceptance of implantable devices, especially in emerging economies.

However, the market growth is not without challenges. High treatment costs and rigorous regulatory approval processes continue to hamper the adoption rate in some regions. Nevertheless, advancements in biomaterials and minimally invasive implant technologies are expected to open new doors for growth.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/2656

Segment Overview
The market is segmented based on product type, biomaterial, and region.

By Product Type:
Orthopedic implants led the market in 2019, capturing nearly 40% of the global share. This dominance is expected to continue due to the rise in joint replacement surgeries and sports injuries.

Notably, this segment is also forecasted to grow at the fastest CAGR of 7.3% through 2027.

Other key segments include cardiovascular implants, spinal implants, neurostimulators, ophthalmic implants, dental implants, facial implants, and breast implants.

By Biomaterial:
Metallic biomaterials held the largest share in 2019, accounting for nearly two-thirds of the market. Their durability and biocompatibility make them ideal for orthopedic and dental implants.

Polymer-based biomaterials, though smaller in current share, are expected to grow at a CAGR of 9.4%, the highest among all biomaterial types, driven by their versatility and use in cosmetic and cardiovascular implants.

Regional Insights
North America dominated the global landscape in 2019, commanding over 40% of the market share, thanks to a well-established healthcare infrastructure, high awareness, and early adoption of advanced medical technologies.

Asia-Pacific, on the other hand, is emerging as a hotbed for growth, projected to register the fastest CAGR of 8.8%. Countries like China and India are witnessing increased healthcare spending, growing medical tourism, and a rising burden of lifestyle-related diseases.

Key Players Shaping the Market
Prominent companies driving innovation and competitiveness in the global medical implant market include:

Medtronic Plc.

Johnson & Johnson

Boston Scientific Corporation

NuVasive, Inc.

Biotronik

LivaNova PLC

Conmed Corporation

Globus Medical, Inc.

Integra LifeSciences Holding Corporation

Institut Straumann AG

These players are focusing on strategic acquisitions, product innovations, and regional expansion to enhance their market presence.

Key Takeaways:
📈 Market size: $85.38 Bn (2019) → $147.46 Bn (2027)

🚀 Fastest-growing product: Orthopedic implants (CAGR 7.3%)

🧬 Top biomaterial CAGR: Polymers (9.4%)

🌍 Fastest-growing region: Asia-Pacific (CAGR 8.8%)

🏥 Top players: Medtronic, Johnson & Johnson, Boston Scientific, and others

As the global demand for better health outcomes and quality of life continues to grow, the medical implant industry is well-positioned for steady and transformative growth, especially with continued R&D and supportive healthcare policies.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/2656

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X